Blue Sparrow’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.9M Buy
+486,700
New +$12.7M 0.15% 100

Other funds holding ARQT

Blue Sparrow's ARQT Position: Q3 2026 in Review

Blue Sparrow opened a new position in Arcutis Biotherapeutics (ARQT) in Q3 2026: 486,700 shares worth $12.9M. The stake represents 0.15% of the portfolio and ranks #100 among its holdings.

294 funds tracked by Wall St. Rank hold ARQT as of Q3 2026.

  • Blue Sparrow held 486,700 shares of Arcutis Biotherapeutics worth $12.9M as of Q3 2026.
  • Arcutis Biotherapeutics was a new Blue Sparrow position in Q3 2026.
  • Arcutis Biotherapeutics made up 0.15% of Blue Sparrow's portfolio in Q3 2026, its #100 holding.
  • 294 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q3 2026.

Based on Blue Sparrow's 13F filing for Q3 2026, filed 16 Nov 2026.